Annual Total Debt
$240.20 K
-$111.10 K-31.63%
31 December 2023
Summary:
Inhibikase Therapeutics annual total debt is currently $240.20 thousand, with the most recent change of -$111.10 thousand (-31.63%) on 31 December 2023. During the last 3 years, it has fallen by -$78.80 thousand (-24.70%). IKT annual total debt is now -35.74% below its all-time high of $373.80 thousand, reached on 31 December 2019.IKT Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$145.20 K
-$32.60 K-18.34%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly total debt is currently $145.20 thousand, with the most recent change of -$32.60 thousand (-18.34%) on 30 September 2024. Over the past year, it has dropped by -$124.80 thousand (-46.22%). IKT quarterly total debt is now -88.33% below its all-time high of $1.24 million, reached on 31 March 2021.IKT Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.6% | -46.2% |
| 3 y3 years | -24.7% | -41.7% |
| 5 y5 years | +2.8% | +100.0% |
IKT Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.6% | at low | -61.2% | |
| 5 y | 5 years | -35.7% | +2.8% | -88.3% | |
| alltime | all time | -35.7% | +2.8% | -88.3% |
Inhibikase Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $145.20 K(-18.3%) |
| June 2024 | - | $177.80 K(-15.1%) |
| Mar 2024 | - | $209.50 K(-12.8%) |
| Dec 2023 | $240.20 K(-31.6%) | $240.20 K(-11.0%) |
| Sept 2023 | - | $270.00 K(-9.4%) |
| June 2023 | - | $298.00 K(-8.3%) |
| Mar 2023 | - | $325.00 K(-7.5%) |
| Dec 2022 | $351.30 K(+41.1%) | $351.30 K(-6.1%) |
| Sept 2022 | - | $374.00 K(>+9900.0%) |
| June 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $248.90 K | $248.90 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $248.90 K(0.0%) |
| June 2021 | - | $248.90 K(-80.0%) |
| Mar 2021 | - | $1.24 M(+289.9%) |
| Dec 2020 | $319.00 K(-14.7%) | $319.00 K(-55.5%) |
| Sept 2020 | - | $717.50 K(+7.2%) |
| June 2020 | - | $669.30 K(+1.9%) |
| Mar 2020 | - | $656.60 K(+75.7%) |
| Dec 2019 | $373.80 K(+59.9%) | $373.80 K(>+9900.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00 |
| Dec 2018 | $233.70 K | - |
FAQ
- What is Inhibikase Therapeutics annual total debt?
- What is the all time high annual total debt for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual total debt year-on-year change?
- What is Inhibikase Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly total debt year-on-year change?
What is Inhibikase Therapeutics annual total debt?
The current annual total debt of IKT is $240.20 K
What is the all time high annual total debt for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual total debt is $373.80 K
What is Inhibikase Therapeutics annual total debt year-on-year change?
Over the past year, IKT annual total debt has changed by -$111.10 K (-31.63%)
What is Inhibikase Therapeutics quarterly total debt?
The current quarterly total debt of IKT is $145.20 K
What is the all time high quarterly total debt for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly total debt is $1.24 M
What is Inhibikase Therapeutics quarterly total debt year-on-year change?
Over the past year, IKT quarterly total debt has changed by -$124.80 K (-46.22%)